M
Mihail Buse
Researcher at Iuliu Hațieganu University of Medicine and Pharmacy
Publications - 15
Citations - 618
Mihail Buse is an academic researcher from Iuliu Hațieganu University of Medicine and Pharmacy. The author has contributed to research in topics: Cancer & Drug resistance. The author has an hindex of 7, co-authored 15 publications receiving 282 citations.
Papers
More filters
Journal ArticleDOI
A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer.
Cornelia Braicu,Mihail Buse,Constantin Ioan Busuioc,Rares Drula,Diana Gulei,Lajos Raduly,Alexandru Rusu,Alexandru Irimie,Atanas G. Atanasov,Ondrej Slaby,Calin Ionescu,Ioana Berindan-Neagoe +11 more
TL;DR: New insights are discussed into MAPK as a complex cell signaling pathway with roles in the sustenance of cellular normal conduit, response to cancer therapy, and activation of compensatory pathways.
Journal ArticleDOI
Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression.
Cornelia Braicu,Rares Buiga,Roxana Cojocneanu,Mihail Buse,Lajos Raduly,Laura Pop,Sergiu Chira,Liviuta Budisan,Ancuta Jurj,Cristina Ciocan,Lorand Magdo,Alexandru Irimie,Florentin Dobrota,Bogdan Petrut,Ioana Berindan-Neagoe +14 more
TL;DR: Altered miRNAs patterns are interrelated to bladder tumorigenesis, allowing them to be used for the development of novel diagnostic and prognostic biomarkers, and can assist for better patient diagnosis.
Journal ArticleDOI
Gold nanorods: from anisotropy to opportunity. An evolution update
Anca Onaciu,Cornelia Braicu,Alina-Andreea Zimta,Alin Moldovan,Rares Stiufiuc,Mihail Buse,Cristina Ciocan,Smaranda Buduru,Ioana Berindan-Neagoe +8 more
TL;DR: Gold nanorods are the most studied anisotropic gold nanoparticles because of the presence of two absorption peaks according to their longitudinal and transversal plasmon resonances, which provide the absorption in the near-infrared region.
Journal ArticleDOI
The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer “Omics”
Cristina Alexandra Ciocan-Cartita,Ancuța Jurj,Mihail Buse,Diana Gulei,Cornelia Braicu,Lajos Raduly,Roxana Cojocneanu,Lavinia Lorena Pruteanu,Cristina Adela Iuga,Ovidiu Coza,Ioana Berindan-Neagoe +10 more
TL;DR: It is argued that the recent; successful advances in MS technologies towards cancer omics studies provides a strong rationale for its implementation in biomedicine as a whole.
Journal ArticleDOI
Approach to the Adult Acute Lymphoblastic Leukemia Patient
Valentina Sas,Vlad Moisoiu,Patric Teodorescu,Sebastian Tranca,Laura Pop,Sabina Iluta,Sergiu Pasca,Cristina Blag,Sorin Man,Andrei Roman,Catalin Constantinescu,Ioana Rus,Mihail Buse,Bogdan Fetica,Mirela Marian,Cristina Selicean,Ioana Berindan-Neagoe,Bobe Petrushev,Horia Bumbea,Alina Tanase,Mihnea Zdrenghea,Shigeo Fuji,Shigehisa Kitano,Ciprian Tomuleasa +23 more
TL;DR: The newly published data in ALL workup and treatment is presented, putting it into perspective for the attending physician in hematology and oncology.